Dr Kamyar Hadian
Head
Research Center for Health and Environment
Helmholtz Zentrum Munich
Germany
Biography
Dr. Kamyar Hadian is currently the Head of the ‘Assay Development and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany. He has in-depth experience in designing biochemical as well as cell-based assays for High-Throughput and High-Content Screening in various disease areas such as Cancer, Diabetes, Virology, Immunology and more. His current research focus is targeting protein-protein interactions in various cellular signaling processes. Before that, Kamyar studied Biology at the Technical University of Munich (TUM) and gained his PhD at the HelmholtzZentrum München/Ludwig Maximilians University (LMU) in the field of Virology (HIV research). After a short PostDoc period in the field of NF-kB signaling, he was appointed the Head of ‘Assay Development and Screening Platform’ at the HelmholtzZentrum München.
Research Interest
Small molecule Screening (HTS/HCS), Biochemical and cell-based assay development, Drug Discovery
